EU blocks $7.1bn takeover of cancer detection company

08-09-2022

Staff Writer

EU blocks $7.1bn takeover of cancer detection company

JHVEPhoto / Shutterstock.com

Illumina bid would have “stifled innovation” | EU said Illumina was the "unrivalled supplier” of next-generation sequencing systems for genetic and genomic analysis.


Illumina, Grail, European Commission, EU, cancer detection, competition, anti-competition, licensing technology

LSIPR